| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive VP of Ww Sales and Mktg | Executive Vp. of Ww Sales and Mktg | Executive Vp. Sales and Mktg +7 more
1 company
Brent Johnson last filed a Form 4 in April 2020, as Executive VP of Ww Sales and Mktg at IRMD. Brent Johnson's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 3,663 shares of IRMD. The IRMD filings lean toward selling, a net 795,468 shares.
Brent Johnson has 76 Form 4 filings on record from December 2015 to April 2020, all as Executive VP of Ww Sales and Mktg at Iradimed (IRMD), 2015–2020.
The 334 reported transactions were 155 open-market sales, 133 stock awards, 31 option exercises and 11 tax withholdings, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 63 sales worth about $19.1M.
The largest open-market sale was 100,000 shares of IRMD at an average $24.01 on August 3, 2018, about $2.4M.
Shares as reported in the last Form 4 for each company; the most recent is from April 2020. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 9, 2020 | IRMD Iradimed Corp | Executive VP of Ww Sales and Mktg | Sale+OE | 4,000 | $20.11 | $80,440.00 | -57.6% | |
| Apr 8, 2020 | IRMD Iradimed Corp | Executive VP of Ww Sales and Mktg | Sale+OE | 12,000 | $20.04 | $240,520.00 | -80.3% | |
| Apr 2, 2020 | IRMD Iradimed Corp | Executive VP of Ww Sales and Mktg | Sale+OE | 9,211 | $20.09 | $185,065.87 | -75.8% | |
| Mar 26, 2020 | IRMD Iradimed Corp | Executive VP of Ww Sales and Mktg | Sale+OE | 1,594 | $20.13 | $32,088.32 | -35.2% | |
| Mar 6, 2020 | IRMD Iradimed Corp | Executive VP of Ww Sales and Mktg | Sale+OE | 12,000 | $23.11 | $277,260.00 | -80.3% | |
| Mar 4, 2020 | IRMD Iradimed Corp | Executive VP of Ww Sales and Mktg | Sale+OE | 33,674 | $23.91 | $805,002.90 | -92.0% | |
| Feb 25, 2020 | IRMD Iradimed Corp | Executive Vp. of Ww Sales and Mktg | Sale+OE | 12,776 | $26.52 | $338,791.76 | -81.3% | |
| Feb 19, 2020 | IRMD Iradimed Corp | Executive Vp. of Ww Sales and Mktg | Sale+OE | 19,559 | $26.00 | $508,534.00 | -86.9% | |
| Jan 10, 2020 | IRMD Iradimed Corp | Executive Vp. of Ww Sales and Mktg | Sale+OE | 5,000 | $25.30 | $126,500.00 | -63.0% | |
| Jan 9, 2020 | IRMD Iradimed Corp | Executive Vp. of Ww Sales and Mktg | Sale+OE | 24,000 | $24.80 | $595,200.00 | -89.1% |